ANRO logo

ANRO CapEx to Revenue

Current (TTM)0.00%
ANRO CapEx/Revenue (323.81% → 0.00%)
High-resolution chart · PNG

ANRO capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Alto Neuroscience, Inc. Common Stock CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0%
0%
0%
0%
323.8095%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.